Covid-19 : les confinements ont eu un impact délétère sur la sévérité du cancer colorectal métastatique

These contents could be interesting :

Absence d’efficacité du remdesivir chez les patients hospitalisés atteints de Covid-19 et poursuite de l’essai DisCoVeRy pour tester un nouveau médicament antiviral

The Discovery clinical trial was initially launched in France by Inserm in March 2020, to evaluate several possible treatments for COVID-19. Its European expansion was made possible by the....

Better Understanding the Role of a White Blood Cell Type in SARS-CoV-2 Immune Response

Researchers describe how basophils respond to SARS-CoV-2 infection. They show that exposure to the virus activates them, leading to the production of certain cytokines and helping to reduce inflammation....

Medias

Researcher Contact

Alain Thierry

Inserm U1194

e-mail : rf.mresni@yrreiht.niala

Téléphone sur demande

Press Contact

rf.mresni@esserp

Sources

Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer

Thierry AR, Pastor B, Pisareva E, et al.

JAMA Network Open, septembre 2021

DOI : 10.1001/jamanetworkopen.2021.24483